Literature DB >> 19857423

Phentermine cardiovascular safety.

Richard B Rothman, Ed J Hendricks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19857423     DOI： 10.1016/j.ajem.2009.07.014

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  6 in total

1.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  J Spinal Cord Med       Date:  2019-06-10       Impact factor: 1.985

Review 2.  Cardiovascular effects of antiobesity drugs: are the new medicines all the same?

Authors:  Mauro Cataldi; Angelo Cignarelli; Francesco Giallauria; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

3.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

4.  High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor.

Authors:  Nicholas T Bello; Amy L Walters; Jessica L Verpeut; Priscila P Cunha
Journal:  J Obes       Date:  2013-01-30

5.  Phentermine-topiramate: First combination drug for obesity.

Authors:  Jagjit Singh; Rajiv Kumar
Journal:  Int J Appl Basic Med Res       Date:  2015 May-Aug

Review 6.  Phentermine and topiramate for the management of obesity: a review.

Authors:  Gina Cosentino; Ariane O Conrad; Gabriel I Uwaifo
Journal:  Drug Des Devel Ther       Date:  2011-04-05       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.